Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8044
Reference
Drug alert 01/2024
Name
Drug alert class 4 drug alert 1 2024 – Class 4 medicines defect information – caution in use – Quadrant Pharmaceuticals Ltd – Cozaar 100mg film-coated tablets
Categories
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
MEDICINES RECALL
Description
Quadrant Pharmaceuticals Ltd has informed the MHRA of an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Cozaar 100mg film-coated tablets. The PIL does not include the most up to date safety information as described below. In Section 2 ‘What you need to know before you take Cozaar', sub section 'Cozaar with food and drink' the following information is missing: ‘Grapefruit juice should be avoided while taking Cozaar.’
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-01-04 00:00:00
Click to go back to homepage